9-13 May 2012 • Barcelona, Spain - Estro-events.org

BARCELONA • SuNDAy, 13 MAy 2012
Scientific
cientific PProgramme
rogramme
clInIcal clInIcal InterdIscIplInary physIcs physIcs radIobIology RTT
Looking forward Stem cells RTT responsibilities
and involvement in
research
Dose calculation and
optimisation
Predictive biomarkers
in radiotherapy
Current practice and
moving controversies
topIcs
oF the day
TL
RTT responsibilities
and involvement in
research
TL
What is a stem cell and
why should I care
TL
Models for secondary
cancer induction at
radiotherapy dose.
An update
TL
Biological optimisation
in the clinic
TL
New clinical fractionation
models in head
and neck radiation
therapy
TL
Current practice and
moving points: sarcoma
TL
Current practice and
moving points:
primary brain
08:30 – 09:10
S
RTT responsibilities
and involvement in
research
• The role of the imaging
specialist RTT
• From mould to planning
• How to plan and
implement a clinical
research RTT project
in the department
D
how important are
tumour and normal
tissue stem cells in
radiotherapy
S
Nanoparticles in radiotherapy
• green nanotechnology
in molecular
imaging and therapy
• Physical perspective
on radiation
response modulation
of tumours with gold
nanoparticles
• gold nanoparticles as
radiosensitisers
• Monte Carlo simulation
on dose enhancement
S
Advances in dose calculation
and optimisation
algorithms. Improving
planning efficacy and
plan quality
• MCO for IMRT planning
• MCO in radiation
oncology: from priorisation
to interaction
• Fast and accurate
solution of the
boltzmann radiation
transport equation for
radiotherapy. Theoretical
aspects
• Fast and accurate
solution of the
boltzmann radiation
transport equation
for radiotherapy.
Implementation and
validation
S
how deep does hPV
change h&N treatment
strategy?
CL, RB
• epidemiology and
clinical features
• biology and targeting
of HPV
• HPV positive vs. HPV
negative oropharyngeal
carcinoma:
de-escalating vs.
intensified treatment?
S
Prediction of complete
response can enhance
organ preservation in
rectal cancer
• pCR: a subgroup
of patients with
better survival or
a unsafe surrogate
endpoint
• Diffusion MR prediction:
standard
or research
• PeT-CT prediction
of response of rectal
cancer to neoadjuvant
therapy:
standard or research
• Modelling response
prediction on clinical
and imaging
evidences
S
Current practice and
controversies: brain
tumours
• Combination of
targeted drugs with
radiotherapy in
glioblastoma : from
mechanisms to
therapy
• Low grade gliomas
/ treatment
sequence (current
practice and future
trends)
• brain metastases
09:15 – 10:30
10:30 – 11:00 COFFee bReaK
SESSIONS: TL= Teaching Lecture / S = Symposium /JS = Joint Symposium / D = Debate / PP = Proffered Papers / LI = Look Inside / EU = Session on EU Projects
DISCIPLINES: CL= Clinical / PH= Physics / BRT= Brachytherapy / RB= Radiobiology / RTT= Radiation Technology
Page 20 /// FInal announcement /// eSTRO 31 eSTRO 31 /// FInal announcement /// Page 21
clInIcal clInIcal InterdIscIplInary physIcs physIcs radIobIology RTT
S
Comparison studies:
ongoing research
• gynaecological radiotherapy:
a study to
compare 2D gynaecological
radiotherapy
with IMRT: an ongoing
trial in Ireland
• Ongoing research: Fu
data of a moderate
hypo-fractionation
scheme
• Delineation of rectal
carcinoma: comparison
between prone
and supine position
S
MC platforms, getting
MC easy for routine use
in MP
• SMCP - an efficient
Monte Carlo treatment
planning system
• egSnrc, beaMnrc
Eu
MEDRAPET
uLICE
S
Predictive biomarkers
in radiotherapy
CL, Ph, RB
• Preclinical predictive
essays and
platforms
• Do our mother’s
genes influence tolerance
to radiation?
• use in clinical trials
S
head and neck design:
Radiotherapy techniques
requirements
• IMRT for which
patients and for what
benefit?
• IMRT + IgRT and/or
adaptive
• IMRT for nPC
D
This house believes
that there is still a
role for radiotherapy
in intermediate risk
endometrial cancer
11:00 – 12:00
D2
The house believes that biological optimisation supersedes physical optimisation
12:00 – 12:45
SESSIONS: TL= Teaching Lecture / S = Symposium /JS = Joint Symposium / D = Debate / PP = Proffered Papers / LI = Look Inside / EU = Session on EU Projects
DISCIPLINES: CL= Clinical / PH= Physics / BRT= Brachytherapy / RB= Radiobiology / RTT= Radiation Technology